PP
BLUE

Paloma Partners’s bluebird bio BLUE Stock Holding History

Paloma Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-124
Closed -$234K – 1297
2018
Q3 		$234K Buy
+124
New +$256K ﹤0.01% 1328
2018
Q1 		– Sell
-154
Closed -$356K – 1950
2017
Q4 		$356K Buy
+154
New +$313K ﹤0.01% 1468
2016
Q4 		– Sell
-4,362
Closed -$3.83M – 1969
2016
Q3 		$3.83M Buy
+4,362
New +$3.16M 0.05% 273

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Paloma Partners's BLUE Position: Q4 2020 in Review

Paloma Partners sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 594 shares — an estimated $415K sold.

Paloma Partners first reported a position in BLUE in Q2 2015 and held it in 10 quarters. The position peaked at $22.4M in Q2 2018. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Paloma Partners reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Paloma Partners sold 594 bluebird bio shares in Q4 2020, an estimated $415K.
  • Paloma Partners first reported a position in bluebird bio in Q2 2015 and held it in 10 quarters.
  • Paloma Partners's bluebird bio position peaked at $22.4M in Q2 2018.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.